Skip to content

Neoplasm Of Mature B Cells C1334633

Published: July 22, 2026Updated: August 20, 2026

A group of cancers affecting mature white blood cells that fight infection. Includes various lymphomas and leukemias. Treatment depends on specific type and may include chemotherapy or targeted therapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(oncologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Painless lymphadenopathy

(lymphatic)

Generalized fatigue

(general)

Splenomegaly

(hemic)

Recurrent infections

(immune)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Immunochemotherapy regimens

Standard treatment involving combinations of monoclonal antibodies and chemotherapy agents tailored to the specific mature B-cell neoplasm subtype and patient risk stratification.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Targeted therapy agents

Use of targeted agents such as BTK inhibitors, BCL-2 inhibitors, or other novel agents that target specific molecular pathways in mature B-cell neoplasms.

medication

Additional treatment options

Hematopoietic stem cell transplantation

Potentially curative approach using high-dose chemotherapy followed by autologous or allogeneic stem cell rescue for eligible patients with aggressive or relapsed disease.

procedure

Surveillance and response assessment

Regular imaging studies, laboratory tests including tumor markers, and bone marrow evaluation to assess treatment response and detect early relapse.

monitoring

Infection prevention and supportive lifestyle

Strategies including vaccination, infection avoidance measures, and maintaining general health through balanced nutrition and appropriate activity during and after treatment.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Neoplasm Of Mature B Cells C1334633?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Neoplasm Of Mature B Cells C1334633. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy